What are your thoughts about this announcement?
Advisers to the Centers for Disease Control and Prevention (CDC) this morning voted to end a decades-long recommendation that all infants born in the U.S. receive the hepatitis B vaccine (Hep B) within 12-24 hours of birth.
Instead, for babies born to mothers who test negative for hepatitis B, the committee recommends that families determine whether to give their child the Hep B shot at birth through individual decision-making with their physician.
For infants who don’t get the birth dose, the committee recommends the initial dose of the vaccine not be administered until infants are at least 2 months old.
IMA physicians called the decision a landmark move away from one-size-fits-all mandates and toward a more patient-centered model of care. During the committee’s deliberations, ACIP members repeatedly emphasized the need to restore clinical judgment, respect parental involvement, and ensure that medical decisions reflect individual health circumstances, not federal blanket directives.
“This is a meaningful course correction,” said Dr. Joseph Varon, IMA President and Chief Medical Officer. “For the first time in years, we’re seeing federal advisory bodies acknowledge what frontline physicians have always known: medicine must be individualized. No family should ever again face the kind of coercive mandates we saw during COVID. Today’s ACIP vote is an encouraging step toward rebuilding trust between patients and public-health institutions.”
Today’s action aligns directly with the IMA’s Parents’ Healthcare Bill of Rights, released in August, which outlined seven core protections to safeguard parental authority, require transparency, guard against overmedicalization, and reaffirm the centrality of the doctor–patient relationship. The document also called for an end to universal medical mandates in favor of personalized clinical decision-making.
“ACIP’s decision is a balanced approach which will allow us to get even more data and make better choices,” Dr. Varon added. “When medical choices are guided by evidence, individualized risk, and the trusted relationship between a family and their doctor, patients win, and public health is strengthened.”